These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38473953)

  • 101. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
    Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
    [No Abstract]   [Full Text] [Related]  

  • 103. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice.
    Schlange C; Müller J; Imhof D; Hänggeli KPA; Boubaker G; Ortega-Mora LM; Wong HN; Haynes RK; Van Voorhis WC; Hemphill A
    Exp Parasitol; 2023 Dec; 255():108655. PubMed ID: 37981259
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target.
    Hu L; Liu Y; Fu C; Zhao J; Cui Q; Sun Q; Wang H; Lu L; Dai H; Xu X; Yang W
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770773
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Identification of potent anti-Cryptosporidium new drug leads by screening traditional Chinese medicines.
    Kabir MHB; Recuenco FC; Mohd Zin NK; Watanabe N; Fukuda Y; Bando H; Watanabe K; Bochimoto H; Xuan X; Kato K
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010947. PubMed ID: 36441814
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis Through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis.
    Xu SJ; Jin B; Zhao WJ; Chen XX; Tong YY; Ding XF; Chen YY; Wang DH; Wang ZM; Dai BQ; Chen S; Liang Y; Chen G; Pan SJ; Xu LL
    Front Oncol; 2022; 12():817660. PubMed ID: 35769717
    [TBL] [Abstract][Full Text] [Related]  

  • 110. An update on
    Dhal AK; Panda C; Yun SI; Mahapatra RK
    J Parasit Dis; 2022 Sep; 46(3):923-939. PubMed ID: 35755159
    [No Abstract]   [Full Text] [Related]  

  • 111. Is
    Certad G
    Food Waterborne Parasitol; 2022 Jun; 27():e00153. PubMed ID: 35498550
    [TBL] [Abstract][Full Text] [Related]  

  • 112. High-Throughput Screening of a Marine Compound Library Identifies Anti-
    Bone Relat RM; Winder PL; Bowden GD; Guzmán EA; Peterson TA; Pomponi SA; Roberts JC; Wright AE; O'Connor RM
    Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447913
    [No Abstract]   [Full Text] [Related]  

  • 113. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
    Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
    [No Abstract]   [Full Text] [Related]  

  • 114. Comparative Characterization of CpCDPK1 and CpCDPK9, Two Potential Drug Targets Against Cryptosporidiosis.
    Su J; Shen Y; Li N; Li Y; Zhang Z; Xiao L; Guo Y; Feng Y
    Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208789
    [TBL] [Abstract][Full Text] [Related]  

  • 115. In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.
    Imhof D; Anghel N; Winzer P; Balmer V; Ramseier J; Hänggeli K; Choi R; Hulverson MA; Whitman GR; Arnold SLM; Ojo KK; Van Voorhis WC; Doggett JS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():90-101. PubMed ID: 34030110
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.